Avanir Pharmaceuticals (Nasdaq: AVNR) 110.7% HIGHER; received FDA approval for NUEDEXTA as the first treatment for pseudobulbar affect. Pseudobulbar affect, or PBA, occurs secondary to a number of unrelated neurological condition, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. Wilmington Trust (NYSE: W...

Avanir Pharmaceuticals (Nasdaq: AVNR) 73.8% HIGHER; received FDA approval for NUEDEXTA as the first treatment for pseudobulbar affect. Pseudobulbar affect, or PBA, occurs secondary to a number of unrelated neurological condition, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. Reddy Ice Holdings (NYSE: ...

Better-than-expected earnings from Baker Hughes helped buoy the energy sector in early trading as investors looked ahead to a possible Federal Reserve decision on quantitative easing and the mid-term elections ...

Surprisingly strong Chinese and US manufacturing data provided investors with something to chew over other than the fast-looming, and crucial, decision on further quantitative easing from the Federal Reserve ...

The German auto sector gains in a flat European market on speculation that third-quarter results from BMW will beat forecasts ...

Money has flowed out of equity funds this year at a startling pace, but this has been reversing tentatively since the start of September ...

In Japan, sentiment was undermined by poor corporate announcements combined with uncertainty about monetary policy ...

Here is a recap of the top news items from this week on Wall Street: 1. The Federal Reserve’s new monetary stimulus measure, or QE2, will be unveiled next week according to reports from the Wall Street Journal. The Fed is expected to announced a program of U.S. Treasury bond purchases worth a few hundred billion dollars over several months. T...

This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High: Maxim Integrated Products Inc. (Nasdaq: MXIM) high of $21.99. After the market yesterday, the company reported an EPS of $0.43 on revs of $626.1 million, topping the consensus EPS of $0.37 on revs of $614.02 million....

The Trading Radar highlights key earnings and economic announcements for tomorrow’s trading session: Before The Market Opens Economics: 8:30am EDT Personal Income - Street sees 0.2% Personal Spending - Street sees 0.4% PCE Prices: Core - Street sees 0.0% Earnings: AAON Inc (Nasdaq: AAON) - consensus EPS $0.35 Acorda Therapeutics (Nasdaq: ACO...